том 29 издание 3 страницы 188-190

Gadolinium-chlorin is potentially a new tumor specific MRI contrast agent

Тип публикацииJournal Article
Дата публикации2006-03-01
scimago Q1
wos Q1
БС1
SJR1.87
CiteScore14.4
Impact factor7.5
ISSN02536269, 19763786
Organic Chemistry
Drug Discovery
Molecular Medicine
Краткое описание
In this study, a newly-synthesized metalloporphyrin, Gd-chlorin (PB Chlorin), was investigated by using a simple tissue phantom to test its efficacy as an MRI contrast, agent. This study demonstrated the potential activity of Gd-chlorin as not only a MRI contrast agent, but also as a PDT photosensitizer by using a simple tissue phantom and conducting a very brief MRI experiment.
Найдено 
Для доступа к списку цитирований публикации необходимо авторизоваться.

Топ-30

Журналы

1
Journal of Porphyrins and Phthalocyanines
1 публикация, 16.67%
BMC Complementary and Alternative Medicine
1 публикация, 16.67%
Nature Communications
1 публикация, 16.67%
Mendeleev Communications
1 публикация, 16.67%
Optical Probes in Biology
1 публикация, 16.67%
Advances in Inorganic Chemistry
1 публикация, 16.67%
1

Издатели

1
2
Springer Nature
2 публикации, 33.33%
Elsevier
2 публикации, 33.33%
World Scientific
1 публикация, 16.67%
Taylor & Francis
1 публикация, 16.67%
1
2
  • Мы не учитываем публикации, у которых нет DOI.
  • Статистика публикаций обновляется еженедельно.

Вы ученый?

Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
6
Поделиться
Цитировать
ГОСТ |
Цитировать
KIM J. et al. Gadolinium-chlorin is potentially a new tumor specific MRI contrast agent // Archives of Pharmacal Research. 2006. Vol. 29. No. 3. pp. 188-190.
ГОСТ со всеми авторами (до 50) Скопировать
KIM J., Kim D. M., KANG M. S., Kim H., Kim J., Yu E., Jeong J. H. Gadolinium-chlorin is potentially a new tumor specific MRI contrast agent // Archives of Pharmacal Research. 2006. Vol. 29. No. 3. pp. 188-190.
RIS |
Цитировать
TY - JOUR
DO - 10.1007/bf02969390
UR - https://doi.org/10.1007/bf02969390
TI - Gadolinium-chlorin is potentially a new tumor specific MRI contrast agent
T2 - Archives of Pharmacal Research
AU - KIM, JONG-KI
AU - Kim, Dong Myung
AU - KANG, MIN SUK
AU - Kim, Hae-Kyung
AU - Kim, Jeong-Sook
AU - Yu, Eun-Kyung
AU - Jeong, Jin Hyun
PY - 2006
DA - 2006/03/01
PB - Pharmaceutical Society of Korea
SP - 188-190
IS - 3
VL - 29
PMID - 16596988
SN - 0253-6269
SN - 1976-3786
ER -
BibTex |
Цитировать
BibTex (до 50 авторов) Скопировать
@article{2006_KIM,
author = {JONG-KI KIM and Dong Myung Kim and MIN SUK KANG and Hae-Kyung Kim and Jeong-Sook Kim and Eun-Kyung Yu and Jin Hyun Jeong},
title = {Gadolinium-chlorin is potentially a new tumor specific MRI contrast agent},
journal = {Archives of Pharmacal Research},
year = {2006},
volume = {29},
publisher = {Pharmaceutical Society of Korea},
month = {mar},
url = {https://doi.org/10.1007/bf02969390},
number = {3},
pages = {188--190},
doi = {10.1007/bf02969390}
}
MLA
Цитировать
KIM, JONG-KI, et al. “Gadolinium-chlorin is potentially a new tumor specific MRI contrast agent.” Archives of Pharmacal Research, vol. 29, no. 3, Mar. 2006, pp. 188-190. https://doi.org/10.1007/bf02969390.